FDA Approved: KIONEX — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' original application for KIONEX (sodium polystyrene sulfonate) to treat hyperkalemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• KIONEX (Sodium polystyrene sulfonate)

Snippet

ORIG AP for KIONEX (SODIUM POLYSTYRENE SULFONATE)